Firethorn Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Firethorn Wealth Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,477	Closed	-$239K	–	140
2021 Q4	$239K	Buy	+1,477	New	+$239K	0.18%	111
2021 Q2	$260K	Sell	1,507 -60	-4%	-$9.91K	0.22%	100
2021 Q1	$252K	Buy	1,567 +30	+2%	+$5.14K	0.23%	96
2020 Q4	$258K	Buy	+1,537	New	+$249K	0.28%	77

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Firethorn Wealth Partners's FBT Position: Q1 2022 in Review

Firethorn Wealth Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2022, closing a stake of 1,477 shares — an estimated $239K sold.

Firethorn Wealth Partners first reported a position in FBT in Q4 2020 and held it in 4 quarters. The position peaked at $260K in Q2 2021. 220 funds tracked by Wall St. Rank hold FBT as of Q1 2022.

Firethorn Wealth Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2022 after selling out during the quarter.
Firethorn Wealth Partners sold 1,477 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2022, an estimated $239K.
Firethorn Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and held it in 4 quarters.
Firethorn Wealth Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $260K in Q2 2021.
220 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.

Based on Firethorn Wealth Partners's 13F filing for Q1 2022, filed 3 May 2022.